Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer

Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer

Abstract Emerging proof shows that abnormal lipometabolism affects invasion, metastasis, stemness and tumor microenvironment in carcinoma cells. However, molecular markers related to lipometabolism have not been further established in breast cancer. In addition, numerous studies have been conducted...

Full description

Bibliographic Details
Main Authors:	Lei Zhang, Risheng She, Jianlin Zhu, Jin Lu, Yuan Gao, Wenhua Song, Songwang Cai, Lu Wang
Format:	Article
Language:	English
Published:	BMC 2022-10-01
Series:	BMC Cancer
Subjects:	Lipometabolism Tumor microenvironment Immunotherapy Chemotherapy Breast cancer
Online Access:	https://doi.org/10.1186/s12885-022-10110-8

Similar Items

Neurodevelopmental trajectories, polygenic risk, and lipometabolism in vulnerability and resilience to schizophrenia
by: Jia Duan, et al.
Published: (2023-03-01)

Microbial and metabolomic insights into the bovine lipometabolic responses of rumen and mammary gland to zymolytic small peptide supplementation
by: En Liu, et al.
Published: (2022-09-01)

Metagenomic insights into the modulatory effects of kelp powder (Thallus laminariae)-Treated dairy milk on growth performances and physiological lipometabolic processes of kunming mice
by: Fuguang Xue, et al.
Published: (2022-09-01)

Untargeted Metabolomics Analysis Revealed Lipometabolic Disorders in Perirenal Adipose Tissue of Rabbits Subject to a High-Fat Diet
by: Siqi Xia, et al.
Published: (2021-08-01)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
by: Ting-Ting Yin, et al.
Published: (2022-08-01)

The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy
by: Andrea Nicolini, et al.
Published: (2024-03-01)

Breast cancer organoids and their applications for precision cancer immunotherapy
by: Dandan Guan, et al.
Published: (2023-10-01)

Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer
by: James W. Opzoomer, et al.
Published: (2019-07-01)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
by: Yangyang Wang, et al.
Published: (2022-01-01)

Tumor Microenvironment Characterization for Assessment of Recurrence and Survival Outcome in Gastric Cancer to Predict Chemotherapy and Immunotherapy Response
by: Yan Chen, et al.
Published: (2022-04-01)

Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness
by: Robby Barnestein, et al.
Published: (2022-12-01)

The interplay between eosinophils and T cells in breast cancer immunotherapy
by: Ioannis Zerdes, et al.
Published: (2023-04-01)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
by: Xue Wang, et al.
Published: (2022-11-01)

Angiotensin-converting enzyme 2 identifies immuno-hot tumors suggesting angiotensin-(1–7) as a sensitizer for chemotherapy and immunotherapy in breast cancer
by: Jie Mei, et al.
Published: (2022-10-01)

Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer
by: Chen L, et al.
Published: (2023-10-01)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
by: Xinpei Deng, et al.
Published: (2023-08-01)

Moxibustion Enhances Chemotherapy of Breast Cancer by Affecting Tumor Microenvironment
by: Xue N, et al.
Published: (2020-09-01)

Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022
by: Fanli Qu, et al.
Published: (2024-12-01)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
by: Jin Wu, et al.
Published: (2022-10-01)

Necroptosis-related KLRB1 was a potent tumor suppressor and immunotherapy determinant in breast cancer
by: Jie Xia, et al.
Published: (2024-03-01)

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
by: Yangyang Guo, et al.
Published: (2023-01-01)

Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
by: Hanxiao Cui, et al.
Published: (2023-03-01)

Effects of chemotherapy and immunotherapy on microbial diversity in TME and engineered bacterial-mediated tumor therapy
by: Heng Zheng, et al.
Published: (2023-02-01)

Emerging nanomedicines for effective breast cancer immunotherapy
by: Amirhossein Bahreyni, et al.
Published: (2020-12-01)

Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma
by: Jun Zhu, et al.
Published: (2022-07-01)

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
by: Yangyang Guo, et al.
Published: (2023-05-01)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
by: Zilan Ye, et al.
Published: (2022-05-01)

Progress for Immunotherapy in Inflammatory Breast Cancer and Emerging Barriers to Therapeutic Efficacy
by: Regina M. Koch, et al.
Published: (2021-05-01)

Correlation Between Immune-Related Genes and Tumor-Infiltrating Immune Cells With the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Yan Zhou, et al.
Published: (2022-06-01)

Tumor Microenvironment Characterization in Breast Cancer and an Immune Cell Infiltration Score Development, Validation, and Application
by: Lang Li
Published: (2022-06-01)

Effects of exercise training in hypoxia versus normoxia on fat-reducing in overweight and/or obese adults: A systematic review and meta-analysis of randomized clinical trials
by: Shuning Chen, et al.
Published: (2022-08-01)

Advances in immunotherapy for triple-negative breast cancer
by: Yang Liu, et al.
Published: (2023-09-01)

Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma
by: Caibao Lu, et al.
Published: (2022-09-01)

Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
by: María Luisa Sánchez-León, et al.
Published: (2023-03-01)

Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy
by: Yu-Han Wen, et al.
Published: (2022-12-01)

Identification of cuproptosis-related patterns and construction of a scoring system for predicting prognosis, tumor microenvironment-infiltration characteristics, and immunotherapy efficacy in breast cancer
by: Wei Li, et al.
Published: (2022-09-01)

Identification of a novel necroptosis-related classifier to predict prognosis and guide immunotherapy in breast invasive carcinoma
by: Qin Zhou, et al.
Published: (2022-09-01)

Editorial: Exploring the breast tumor microenvironment: Association to metastasis, novel risk factors and novel treatments and immunotherapies
by: Karen Elizabeth Nava-Castro, et al.
Published: (2022-12-01)

Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer
by: Jana Plava, et al.
Published: (2021-09-01)

Enhancing the Treating Efficacy of Immunotherapy through the Restructure of Tumor Microenvironment
by: Bokai Gong, et al.
Published: (2023-12-01)